The AffiELISA® Human Anti-PLP1 Kit uses competitive inhibition enzyme immunoassay technique. The provided microtiter plate comes pre-coated with Anti-Proteolipid Protein 1, Myelin Antibody (Anti-PLP1) protein. To perform the assay, standards or samples are added to designated wells on the microtiter plate. Subsequently, a biotin-conjugated antibody specific to Anti-Proteolipid Protein 1, Myelin Antibody (Anti-PLP1) is introduced. Avidin conjugated to Horseradish Peroxidase (HRP) is then added to each well, followed by an incubation period. Afterward, the TMB substrate solution is added, initiating an enzyme-substrate reaction. To conclude the reaction, a sulphuric acid solution is introduced, causing a color change that can be measured spectrophotometrically at a wavelength of 450nm ± 10nm. By comparing the optical density (OD) of the samples to the standard curve, the concentration of Anti-Proteolipid Protein 1, Myelin Antibody (Anti-PLP1) in the samples can be determined.
AffiELISA® Human Anti-PLP1 Kit
Anti-Proteolipid Protein 1, Myelin Antibody
MMPL - PLP/DM20 - PMD - SPG2 - Pelizaeus-Merzbacher Disease - Spastic Paraplegia 2,Uncomplicated - Myelin proteolipid protein - Lipophilin
Human
Competitive Inhibition ELISA
Serum, plasma and other biological fluids.
Neuroscience.